Research papersA comparison of population-based cancer incidence rates in Israel and JordanFreedman, L.S.1 2; Barchana, M.3; Al-Kayed, S.4; Qasem, M.B.4; Young, J.L.5; Edwards, B.K.6; Ries, L.A.G.7; Roffers, S.5; Harford, J.8; Silbermann, M.1 9Author Information 1Middle East Cancer Consortium 2Department of Mathematics and Statistics, Bar Ilan University, Ramat Gan, Israel 3Israel Cancer Registry, MOH, Jerusalem, Israel 4Jordan Cancer Registry, MOH, Amman, Jordan 5Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA 6Surveillance Research Program, National Cancer Institute, NIH, Bethesda, MD, USA 7SEER Program, National Cancer Institute, NIH, Bethesda, MD, USA 8Office of International Affairs, National Cancer Institute, NIH, Bethesda, MD, USA 9Department of Anatomy and Cell Biology, Technion, Israel Institute of Technology, Haifa, Israel Correspondence to: L Freedman, Department of Mathematics, Statistics and Computer Science, Bar Ilan University, Ramat Gan 52900, Israel Fax: (+972) 3 534 9607. E-mail: firstname.lastname@example.org or email@example.com Received 4 March 2003 Accepted 20 May 2003 European Journal of Cancer Prevention: October 2003 - Volume 12 - Issue 5 - p 359-365 Buy Abstract Reliable information about comparative cancer incidence in the Middle East has been lacking. The Middle East Cancer Consortium (MECC) has formed a network of population-based registries with standardized basic data. Here the age-adjusted cancer incidences are compared for four populations: Israeli Jews, Israeli non-Jews, Jordanians and the US Surveillance Epidemiology and End Results (SEER) population, for the years 1996–1997 (Israel) and 1996–1998 (other populations). The all-sites rate of cancer is approximately twice as high in Israeli Jews and SEER, compared with Israeli non-Jews and Jordanians. Rates of lung cancer are similar among Israeli Jews and non-Jews and about twice as high as in Jordanians. Childhood leukaemia rates in Jordan are higher than in Israeli Jews, but lower than SEER. Hodgkin lymphoma rates in Israeli non-Jews and Jordanians are similar to SEER, but non-Hodgkin lymphoma rates are lower than SEER. The previous suspicion of higher overall leukaemia and lymphoma rates in Jordan is thus not confirmed. © 2003 Lippincott Williams & Wilkins, Inc.